To assess whether changes in incidence were more marked in certain age groups (as observed overseas [3], [4]), patients were also categorised into three bands according to age at diagnosis: 0–4 yr (children less than 5 yr), 5–9 yr (equal or greater than 5 yr but less than 10 yr), and 10–14 yr (equal or greater than 10 yr but less than 15 yr). These age bands also match national census classifications. The incidence of type 1 diabetes was assessed as the number of new diagnoses per 100,000 age-matched inhabitants on a given year, based on the 5-yearly national census data from Statistics New Zealand [12] and interpolated estimates of the population for the intervening years. Incidence was modelled using the Poisson distribution. Point estimates were calculated with exact Poisson confidence limits, and change in incidence over time were analysed using Poisson regression. Changes in patient numbers, age at diagnosis, and anthropometric data over time were assessed by linear regression. Poisson modelling was undertaken using StatsDirect v2.7.8 (StatsDirect Ltd, UK); other analyses were undertaken using JMP v. 5.1 (SAS Inc, USA).
Data sharing: The research team will consider reasonable requests for sharing of deidentified patient level data. Requests should be made to the corresponding author. Consent for data sharing was not obtained but the presented data are anonymised and risk of identification is low. The original protocol30 is available from the corresponding author on request.
A nine month, two arm, parallel, randomised controlled trial was conducted in adults with poorly controlled diabetes between June 2015 and August 2017. The study received ethical approval from the Health and Disability Ethics Committee (14/STH/162), and the protocol was published30 and registered with the Australian New Zealand Clinical Trials Registry (ACTRN12614001232628). Trial development and reporting was guided by the CONSORT31 and CONSORT EHEALTH32 statements.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
We are now operating as a Branch of Diabetes New Zealand; previously we had been in operation for more than 30 years, as an independent Incorporated Society. During that time, we have seen some significant changes in the field of diabetes. As times change, we strive to change with them, but our basic mission remains the same: to support the interests of people living with diabetes in the Rotorua region.
HOME What is Diabetes What is diabetes? TYPE 1 DIABETES TYPE 2 DIABETES Get Tested for Diabetes Gestational Diabetes ARE YOU AT RISK? COMPLICATIONS YOUTH Resources for Youth #1 Pack and Jerry The Bear Study & Exams Type 1 diabetes newly diganosed packs LIVING WELL LIVING WELL WITH DIABETES Type 1 Diabetes Day to Day Management Type 2 Diabetes Day to Day Management Managing Diabetes Food and Nutrition ANNUAL DIABETES Check ups Travelling to New Zealand RESOURCES RESOURCES Take Control Toolkit Take Control Toolkit APP PAMPHLET ORDERING Diabetes Wellness Magazine Your Stories NEWS AND EVENTS Blog WHO ARE WE WHO IS DIABETES NZ Policies & Constitutions Diabetes NZ Awards Diabetes NZ Team CONTACT US Contact Info JOIN US PLEASE DONATE BRANCHES